A short course of antibiotics as effective at treating TB as the traditional longer course
Until SARS-CoV-2, the bacteria Mycobacterium tuberculosis (pictured) held the top spot as the world’s most deadly infectious agent. Approximately 10 million people fell ill as a result of the bacteria in 2019, and approximately 1.4 million of them died. Tuberculosis, which mostly affects the lungs causing a thick phlegmy cough, fever and weight loss, can be cured, but the hefty drug regimen involves a cocktail of several different antibiotics taken for six months or more. A recent trial involving more than 2000 TB patients, however, has shown that a four-month course of antibiotics can be equally as effective at eliminating the disease. And that’s good news because a shorter course means not only cheaper treatment – especially important for the less affluent countries where TB is prevalent – but also, that any side effects of the drugs, such as stomach upsets, loss of appetite, and itchy skin are also resolved faster.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.